Biliary atresia (BA), a neonatal progressive fibroinflammatory cholangiopathy of unknown etiology, remains the most common cause of end-stage liver disease (ESLD) in children and the most frequent indication for pediatric orthotopic liver transplantation (OLT).
Most pediatric recipients undergoing OLT for BA in the United States are younger than 5 years old and receive a deceased donor whole liver (WL) allograft. (1) According to the United Network for Organ Sharing (UNOS) database, in 2014 there were only 240 livers recovered from deceased donors who were 5 years old or younger, but 449 patients of the same age were added to the liver transplant waiting list (based on Organ Procurement and Transplantation Network data as of December 31, 2014) . This imbalance between availability of size-appropriate pediatric deceased donors and pediatric patients in need of a transplant remains an important obstacle in all pediatric liver transplantation, but it presents a particular challenge for patients with BA. The size constraints of small BA recipients limit their access to WLs necessitating the development of techniques for OLT using reduced size allografts. The introduction of deceased donor partial liver (DDPL) transplantation in 1988 and living donor liver transplantation (LDLT) in 1989 have increased accessibility to liver allografts for all pediatric patients with ESLD. (2, 3) Despite these innovations, whole organ OLT remains the standard of care. Few studies have focused specifically on the outcomes comparing allograft types in the setting of liver transplantation for BA. The aim of this study is to summarize the national outcomes for liver transplantation for BA during the Pediatric End-Stage Liver Disease (PELD) score era based on the UNOS database with specific attention paid to the interaction of allograft type and recipient size on outcome.
Patients and Methods
The study was approved by the appropriate institutional review board. The UNOS database study cohort included all pediatric patients of <18 years of age who underwent a primary liver transplant for BA from January 2, 2002 to December 30, 2014 in the United States. Patients were grouped according to their pretransplant weight (7 kg, 7-14 kg, and >14 kg). The baseline demographic and clinical characteristics analyzed included donor types (WL, DDPL, LDLT), sex, age, disease history, wait time (defined as time in days between listing and transplantation), medical condition prior to transplant (intensive care unit [ICU] utilization, pretransplant hemodialysis, and ventilator dependence), laboratory data (bilirubin, albumin, and international normalized ratio), final Model for EndStage Liver Disease (MELD)/PELD score, MELD/ PELD score exceptions acquired, era of transplantation. Donor characteristics like age and donation after cardiac death (DCD) were also included in the analysis. The maximally selected log-rank statistics method was performed to identify the optimal cutoffs for the numeric variables.
The endpoints of this study were graft and recipient survival. Graft survival was calculated as the time from initial transplant to graft failure; graft failure was defined as retransplantation or patient death. Recipient survival was calculated as the time between initial transplant and death from any cause. For each of these endpoints, if a patient had not experienced the event, the patient was censored at the date of last follow-up. The estimated probability of graft or recipient survival at 1, 5, and 10 years was based on the Kaplan-Meier method. Kaplan-Meier curves and log-rank tests were used to perform univariate analysis of the association between baseline demographic and clinical characteristics with graft and recipient survival. Factors independently associated with graft and recipient survival (P value < 0.05) were then included in multivariate models. Because of the strong correlation between ICU location and ventilator dependence, only ventilator dependence was included in the multivariate analysis as the less subjective variable of the 2 variables. Forest plots were used to demonstrate the hazard ratios (HRs) of donor type utilization in each of the recipient weight groups and to illustrate the HRs for factors in the multivariate models.
The differences of recipient and donor characteristics among the different allograft types were compared within each weight group using a chi-square test for categorical factors and the Kruskal-Wallis test for numeric variables. SAS 9.4 (SAS Institute, Cary, NC) was used to perform all analyses. The maximal selected log-rank statistics were performed in R with package "maxstat." R function "rtf.forest.plot" in the "rtf" package was used to create the forest plots.
Results
The study cohort included 2123 recipients of pediatric liver transplants. These recipients underwent transplantation with either a WL (n 5 1124), LDLT (n 5 340), or DDPL (n 5 659) allograft. The DDPL allografts were comprised of 408 deceased donor splitliver allografts and 250 deceased donor size-reduced allograft. Fifty percent of the transplants were performed in recipients who were <1 year of age (Fig.  1A) . The median weight at the time of transplant was 8 kg (Fig. 1B) . Approximately 33% of transplants were performed in recipients weighing 7 kg; 47% of transplants were performed in recipients weighing 7-14 kg; and 20% of transplants were performed in recipients weighing >14 kg. A WL allograft was used in 53% of all the recipients. The use of a WL allograft progressively increased from 42% in recipients weighing 7 kg to 74% in recipients weighing > 14 kg (Fig.  2) . Conversely, LDLT decreased from 25% in recipients weighing 7 kg to 9% in recipients weighing > 14 kg. The overall 1-, 5-, and 10-year graft survival in the PELD era was 89%, 85%, and 81%, respectively. The overall 1-, 5-, and 10-year patient survival in the PELD era was 94%, 92%, and 90%, respectively. There were no significant differences in the pretransplant characteristics of recipients weighing 7 kg based on type of liver allograft (Table 1) . Recipients of living donor (LD) allografts had significantly shorter cold ischemia times (CITs) and older donor age compared with the deceased donor groups receiving WL or DDPL allografts. In recipients 7 kg, the 1-, 5-, and 10-year graft survival rates were significantly superior for LDLT (91%, 88%, 84%) and DDPL (90%, 84%, 77%) compared with WL (79%, 75%, 74%; P 5 0.005). The 1-, 5-, and 10-year patient survival for recipients 7 kg differed between groups but did not attain statistical significance: LDLT (96%, 95%, 95%), WL (90%, 89%, 87%), and DDPL (94%, 90%, 87%; P 5 0.07; Fig. 3A) .
Recipients weighing 7-14 kg were similar in age, waiting time, and final PELD score regardless of type of liver allograft (Table 2 ). However, WL recipients were most likely to have an exception score (35%) compared with LDLT (20%). Additionally, DDPL NOTE: Data are given as n (%) unless otherwise noted. *P value was based on the chi-square test for categorical factors and the Kruskal-Wallis test for numerical factors.
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recipients were more likely to be in the ICU prior to transplant (15%) compared with WL and LD recipients. Once again, there were significant differences in CIT and donor parameters including age among liver allograft types. The 1-, 5-, and 10-year graft survival was significantly superior for recipients of LDLT (98%, 97%, 92%) compared with either DDPL (88%, 83%, 81%) or WL (87%, 84%, 84%; P 5 0.007). The 1-, 5-, and 10-year patient survival was also significantly superior for recipients of LDLT (98%, 97%, 95%) compared with either DDPL (92%, 90%, 88%) or WL (94%, 92%, 92%; P 5 0.03; Fig. 3B ).
Unlike the other weight groups, recipients weighing >14 kg differed significantly in age at the time of transplant based on allograft type (Table 3) . A substantial percentage of recipients (30% of WL, 12% of DDPL, and 21% of LDLT) fell in the 12-17 years old age group, thus converting them to the MELD scoring system. Although it did not reach statistical significance, there is a trend toward a lower MELD/PELD score in the LDLT group compared with deceased donor allografts. Additionally, none of the LDLT recipients were located in the ICU prior to their transplant. Again, differences were identified in both CIT and donor parameters including age based on allograft type with LD having the shortest CIT and oldest median donor age. The 1-, 5-, and 10-year graft survival was highest but not significant in WL (96%, 91%, 86%) compared with DDPL (85%, 85%, 71%). Although WL graft survival was also higher than LDLT (91%, 78%, 78%), this did not attain statistical significance likely due to sample size (P 5 0.06). The 1-, 5-, and 10-year patient survival was similar in recipients of DDPL (93%, 93%, 89%), LDLT (100%, 92%, 92%), and WL (97%, 95%, 92%; P 5 0.30; Fig. 3C ).
A univariate analysis was performed by recipient weight groups. Allograft type was the variable consistently identified in the univariate analysis as predictive of both graft and patient survival (Tables 4 and 5 ). In the multivariate analysis of recipients weighing 7 kg, LDLT or DDPL recipients had a significantly lower risk of graft failure compared with WL recipients. Pretransplant ventilator utilization was identified as a recipient predictor of decreased patient survival. In recipients weighing 7-14 kg, multivariate analysis identified donor type, pretransplant ventilator utilization, and portal vein thrombosis as predictors of graft survival with LDLT recipients having a decreased risk of graft failure compared with WL recipients. Portal vein thrombosis was the only predictor of patient survival identified in the 7-14 kg weight group. In recipients weighing > 14 kg, multivariate analysis identified a decreased graft and patient survival only in recipients with a pretransplant MELD/PELD score > 20 (Fig. 4) . To examine a potential explanation for the inferior graft survival of WL transplantation in recipients weighing 7 kg, we examined the incidence of vascular thrombosis-associated graft loss by graft type and recipient weight. Recipients weighing 7 kg transplanted with a WL had a 13% incidence of vascular thrombosis-associated graft loss compared with the 5% incidence in DDPL and 6% incidence in LD recipients (P 5 0.002). Conversely, in recipients weighing >14 kg, the highest incidence of vascular thrombosis-associated graft loss was found in LD transplants at 8%, compared with an incidence of 4% in DDPL and only 2% in WL transplants (P 5 0.06; Fig. 5A ). Lastly, we examined the retransplant rate by allograft type within the 3 weight groups. Retransplantation in recipients weighing 7 kg occurred in 16% of the WL compared with 9% in DDPL and 9% in LD recipients (P 5 0.02). However, in recipients weighing > 14 kg the highest retransplant rate of 11% occurred in the LD recipients, with slightly less than 6% of the WL recipients undergoing retransplantation (P 5 0.28; Fig. 5B ). The 1-, 5-, and 10-year survival of patients undergoing retransplantation was 80%, 78%, and 74%, respectively.
Discussion
One of the main barriers to transplantation in pediatric ESLD patients is the availability of a suitably sized organ resulting in infants having the highest pretransplant mortality rate of all pediatric liver transplant candidates.
(1) This is particularly applicable to patients with BA in which the majority of recipients are <1 year of age and weigh <10 kg at the time of transplantation. Because of the limited supply of suitably sized WL allografts, nearly 50% of pediatric liver transplant recipients receive a reduced size technical variant allograft. Both recipient size and liver allograft type have previously been identified as significantly affecting outcomes in pediatric liver transplantation. (1, 4) However, the interaction between these 2 variables has yet to be well characterized.
Most analyses addressing the effect of recipient size on outcome use recipient age rather than weight. Specifically, the 2 largest North American studies examining outcomes in pediatric liver transplantation for BA identified age as an independent predictor of posttransplant mortality. (5, 6) Analysis of the UNOS database in 2005 reported that recipient age independently correlated with 1-year posttransplant survival (HR 5 0.92; P 5 0.03) and decreased age was found to be associated with posttransplant mortality on multivariate analysis. (5) A subset analysis of the Studies of Pediatric Liver Transplantation (SPLIT) database in 2005 confirmed that recipients < 1 year old are at a significantly increased risk of mortality compared with those 1 year of age (relative risk [RR] 5 2.1, 1.07-4.08). (6) However, neither of these 2 studies identified recipient weight as a determinant of posttransplant outcomes. The effect of allograft type on the outcome of liver transplantation for BA has also been examined using the UNOS and SPLIT databases. The UNOS analysis identified a decreased 1-year posttransplant survival in recipients of DDPL allografts (HR 5 2.1; P < 0.001). The SPLIT database analysis reported that recipients of a deceased donor technical variant allograft were at an increased risk of graft failure after transplant (RR 5 1.9, 1.07-3.54). Interestingly, neither analysis identified a survival advantage for recipients of LDLT allografts. Both studies analyzed data primarily from the pre-PELD era, and there have been no subsequent national or large database analyses since. However, the findings of these studies are consistent with outcomes described for pediatric liver transplantation as a whole in which young, small recipients and those receiving deceased donor technical variant grafts have inferior outcomes compared with older, larger recipients and those receiving whole allografts. (1, 4, 7) Only a single study by Roberts et al. (8) in 2004 specifically examined the interaction between recipient age and allograft type and found inferior outcomes in young recipients of WL allografts and older recipients of technical variant allografts.
In our study, we report the outcomes of liver transplantation for BA in the PELD era by examining the UNOS database with specific attention to the interaction between weight and allograft type. Overall, the outcomes of liver transplantation for BA continue to be excellent in the PELD era with 90% of recipients alive at 10 years. However, recipient weight significantly affects graft survival, with recipients weighing 7 kg having the least favorable outcomes. For patients weighing 7 kg, the use of a WL allograft is associated with a significantly increased risk of graft failure compared to either LD or DDPL allografts. Recipients of a WL allograft who weigh 7 kg have the highest rate of vascular thrombosis contributing to graft failure and the highest rate of retransplantation. Conversely, recipients weighing > 14 kg and transplanted with WL allografts have the lowest rate of vascular thrombosis contributing to graft failure as well as the lowest rate of retransplantation. It is likely that the use of a technical variant graft, either a DDPL or LD allograft, in recipients weighing >14 kg also increases the risk of graft loss compared with a WL allograft, but this trend does not attain statistical significance in multivariate analysis due to sample size limitations.
It is well established that pediatric liver transplant recipients have a higher vascular complication rate compared with adult recipients. The largest singlecenter study evaluating vascular thrombosis in liver transplantation compared 866 pediatric OLTs with 3368 adult OLTs and found a significant increase in hepatic artery (7.9% versus 3.9%) and portal vein (5.7% versus 1.0%) thrombosis rates in pediatric liver transplantation compared with adult liver transplantation. (9) Hepatic artery thrombosis was a particularly frequent occurrence during the nascence of pediatric liver transplantation occurring in up to 26% of recipients within the first 2 weeks after transplant. (10) Several subsequent publications soon identified the combination of a young recipient and a WL allograft as being at particularly high risk (25%-29%) for hepatic artery thrombosis. (11) (12) (13) In small recipients with small visceral arteries, fashioning a small caliber anastomosis, particularly with vessels < 3 mm in diameter, increases the risk of thrombosis due to the rheological properties of blood and the low flow associated with vessel diameter. (14) Recipients of DDPL allografts in which the celiac axis was used to fashion a large, direct-to-aorta anastomosis had a very low comparable hepatic artery thrombosis rate. (13) A limitation of this study, inherent to large database analyses, is the lack of granularity. We are not able to examine the effect of the specific technical aspects of a transplant event such as type of arterial reconstruction, utilization of an arterial conduit, or fascial closure technique on outcome. Acquisition of such granular data will require changes in individual transplant event reporting to UNOS.
Although WL remains the most frequently used organ type for transplantation in pediatric patients with ESLD, smaller patients, like the majority of BA recipients, may be better served with DDPL or LD allografts. These allograft types are more readily available than WLs, and our results indicate that they are associated with decreased rates of posttransplant vascular complications and retransplantation, and increased graft and patient survival in recipients weighing 7 kg. However, as recipients grow, the use of technical variants increases the risk of graft failure and is inferior to WL transplantation. Thus, the size of a recipient should strongly influence the type of allograft used to maximize outcome. The liver transplant community should consider increasing access to splitable adult deceased donor livers for small children. This approach, in which the left lateral segment is used for the child, whereas the right trisegmentectomy graft is used for an adult, can significantly improve pediatric graft survival without decreasing the overall number of allografts available to adult recipients. (15) (16) (17) 
